Saturday, September 23News That Matters
Shadow

Tag: those

Germany halts use of AstraZeneca COVID-19 vaccine to those under 60

Germany halts use of AstraZeneca COVID-19 vaccine to those under 60

World
March 31 (UPI) -- German health officials restricted the use of AstraZeneca's COVID-19 vaccine to those over the age of 60 due to concerns of rare yet severe cases of blood clots in younger people who had received the shot. Chancellor Angela Merkel and Health Minister Jens Spahn made the announcement during a press conference on Tuesday to halt administering the drug to those under 60 years of age on the recommendations of the country's independent Standing Vaccination Commission. Advertisement Merkel added that those below 60 may still receive the life-saving jab at a doctor's discretion. Concerning the 2.2 million younger Germans who have already received the first shot of the two-dose regimen, Merkel said the STIKO will make a recommendation by the end of April. "The recommendations o...
Covid jab probably does protect those around you

Covid jab probably does protect those around you

Health
Getty ImagesThe Covid-19 vaccine blocks pretty much all cases of serious illness - but the government has been much more cautious about saying whether it stops people carrying the virus and infecting others. Until evidence had built up from lots of people being vaccinated, scientists could not say for sure if the jab would stop transmission - and there was concern those vaccinated might stop taking precautions, potentially leading to a rise in infections. But with some now refusing the vaccine in the belief it will not stop them passing on the virus, is this caution becoming counterproductive?A number of people have contacted the BBC, saying they believe the jab could stop them becoming severely ill only. Yet the evidence is moving fast.Protection from the vaccine may not be perfect and pe...

First $1,400 stimulus checks will go to those with direct deposit

Finance
Ting Shen/Xinhua via Getty ImagesThe federal government will issue the first batch of $ 1,400 stimulus checks to Americans who gave direct deposit information when they filed taxes for 2019 or 2020, a Treasury Department official confirmed to NBC.The $ 1.9 trillion American Rescue Plan offers one-time direct payments to those who qualify — the third round of stimulus checks since the pandemic began.President Joe Biden signed the Covid relief bill on Thursday.More from Personal Finance:New $ 1,400 stimulus checks could be garnished for unpaid debtsWhat to know about unemployment benefits in the American Rescue PlanDisabled Americans may want to save their stimulus money in this accountSome Americans will receive stimulus checks as soon as this weekend, the White House said Thursday.The i...
Covid-19: Vaccine offers for all those aged 56 or over

Covid-19: Vaccine offers for all those aged 56 or over

Health
EPAPeople aged 56 to 59 in England are being invited to book their coronavirus vaccine from this week. Letters for people in the age group, offering them the vaccine, started being delivered to homes on Saturday. It comes after eight in 10 people aged 65 to 69 have taken up the offer of a jab, NHS England said.But the Office for National Statistics (ONS ) has warned the UK is "not out of the woods yet". More than 18 million people in England have already had one dose of the vaccine - over a third of the entire adult population. The latest figures show that across the UK, nearly 21.4 million people have now had one dose of a Covid-19 vaccine, with more than a million now having had both doses required. When will I get the vaccine? When and how will lockdown end? What is happening to the R ...
Drug prevents, delays Type 1 diabetes in 50% of those at risk, study finds

Drug prevents, delays Type 1 diabetes in 50% of those at risk, study finds

Health
March 3 (UPI) -- Half of those at risk for Type 1 diabetes treated with a new drug remained disease-free five years later, a study published Wednesday by the journal Science Translational Medicine found. Conversely, 22% of people who did not receive the drug remained disease-free five years after the start of the study, the data showed. Advertisement The drug, teplizumab, is a monoclonal antibody -- a synthetic version of the cells produced by the human immune system -- developed by the biotechnology company Provention and is designed to prevent the onset of Type 1 diabetes. Those who developed Type 1 diabetes after receiving teplizumab did so about five years after receiving the new drug, compared with 27 months for study participants who received a placebo, the researchers said. "If ap...